The Rheumatoid Arthritis Drug Baricitinib Is Authorized to Treat Severe COVID-19 (Along with Remdesivir)
The targeted therapy, known as a Janus kinase (JAK) inhibitor, may help people who are hospitalized with COVID-19 recover more quickly when given with the antiviral medication remdesivir.
Continue reading